MBA Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$358K Buy
4,129
+34
+0.8% +$3.26K 0.14% 101
2025
Q4
$393K Sell
4,095
-454
-10% -$44.1K 0.16% 97
2025
Q3
$433K Buy
4,549
+618
+16% +$56.8K 0.19% 93
2025
Q2
$343K Sell
3,931
-135
-3% -$11.4K 0.16% 101
2025
Q1
$365K Buy
4,066
+435
+12% +$38.9K 0.18% 96
2024
Q4
$290K Sell
3,631
-915
-20% -$79.2K 0.15% 105
2024
Q3
$409K Sell
4,546
-26
-0.6% -$2.19K 0.2% 87
2024
Q2
$360K Buy
4,572
+579
+15% +$47.5K 0.18% 89
2024
Q1
$348K Buy
3,993
+586
+17% +$50K 0.18% 90
2023
Q4
$281K Sell
3,407
-560
-14% -$42.7K 0.16% 100
2023
Q3
$311K Buy
3,967
+500
+14% +$41.9K 0.19% 88
2023
Q2
$305K Sell
3,467
-528
-13% -$45.5K 0.18% 90
2023
Q1
$322K Buy
+3,995
New +$326K 0.2% 91
2022
Q4
Sell
-2,636
Closed -$213K 125
2022
Q3
$213K Sell
2,636
-525
-17% -$47.2K 0.15% 115
2022
Q2
$284K Sell
3,161
-260
-8% -$26.3K 0.2% 99
2022
Q1
$380K Buy
3,421
+623
+22% +$65.8K 0.24% 96
2021
Q4
$289K Buy
+2,798
New +$324K 0.18% 119

Other funds holding MDT

MBA Advisors's MDT Position: Q1 2026 in Review

MBA Advisors increased its Medtronic (MDT) stake by 0.83% in Q1 2026, buying an estimated $3.26K and bringing the position to 4,129 shares worth $358K. The position accounts for 0.14% of the portfolio, ranked #101.

MBA Advisors first reported a position in MDT in Q4 2021 and has held it in 17 quarters since. The position peaked at $433K in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • MBA Advisors held 4,129 shares of Medtronic worth $358K as of Q1 2026.
  • MBA Advisors bought 34 Medtronic shares in Q1 2026, an estimated $3.26K.
  • Medtronic made up 0.14% of MBA Advisors's portfolio in Q1 2026, its #101 holding.
  • MBA Advisors first reported a position in Medtronic in Q4 2021 and has held it in 17 quarters since.
  • MBA Advisors's Medtronic position peaked at $433K in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on MBA Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.